Large Animal Immobilon Solution for Injection

Summary of Product characteristics

                                Revised: November 2014
AN: 00750/2014
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Large Animal Immobilon Solution for Injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active Ingredient:
mg/ml
Etorphine
2.25
(as etorphine hydrochloride
2.45)
Acepromazine
7.38
(as acepromazine maleate
10.0)
Preservative:
Chlorocresol
1.0
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear yellow aqueous solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses and deer.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reversible neuroleptanalgesia (narcosis with analgesia) for restraint
and minor
surgical interventions in the horse. The product may also be used in
deer.
4.3
CONTRAINDICATIONS
Do not use in feline species.
Do not use in horses with cardiac arrhythmias or a history of
endocarditis, or with
liver damage.
Do not use intramuscularly in the horse except in the circumstances of
an emergency
where intravenous injection is not possible.
Do not dilute or mix with any other substance.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Animals MUST be kept stabled, protected from extremes of temperature
and under
close supervision for at least 24 hours, particularly for the first 8
hours following
administration.
Care must be taken to avoid hypothermia or hyperthermia (see above).
Protect horses’ eyes from sun or bright light following
administration.
Revised: November 2014
AN: 00750/2014
Page 2 of 6
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Treat animals individually and not in groups.
The use of etorphine, particularly in elderly animals, carries a
degree of risk and
the usual precautionary procedures, such as the maintenance of free
air
passages, must be followed.
In male horses, product use can cause paraphimosis, usually as a
sequel to
priapism.
Use in fallow deer is not recommended.
ii.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animal
                                
                                Read the complete document